AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter.
10x Science raises $4.8M to use AI for identifying promising drug candidates from vast molecular datasets.
•10x Science has secured $4.8 million in seed funding.
•The company utilizes AI to analyze complex molecular data for drug discovery.
•Their goal is to help pharmaceutical researchers pinpoint the most viable drug candidates.
Why it matters
This article highlights how AI is being applied to accelerate the traditionally slow and expensive process of drug discovery. By sifting through massive amounts of molecular data, AI can identify potential drug candidates that might otherwise be missed, potentially leading to faster development of new treatments for diseases. This represents a significant advancement in the application of AI within the healthcare and pharmaceutical sectors.
Impact:◇ Medium
Who should care:FOUNDERS, INVESTORS, GENERAL
Time Horizon:Mid-term
Explain Simply →
A company called 10x Science is using smart computer programs (AI) to look through lots of information about tiny parts of nature. They want to find the best ones that could become new medicines faster than before.
